Money Briefing: This is What Merck & Co. (MRK) is Doing to Mitigate Against KEYTRUDA Exclusivity Loss Strategic angle: Merck & Co. is taking strategic steps to address the impending loss of exclusivity for KEYTRUDA. Editorial Staff Mar 15
Money Briefing: Abbott Laboratories (ABT) Unveils XIENCE Skypoint to Advance Cardiovascular Treatment in India Strategic angle: Abbott Laboratories introduces a new product aimed at improving cardiovascular care in the Indian market. Editorial Staff Mar 15
Money Briefing: Thermo Fisher Scientific Inc. (TMO) Positioned for Robust Growth on AI Integration and Acquisition Boost Strategic angle: Thermo Fisher Scientific Inc. (TMO) is set for significant growth driven by advancements in AI and strategic acquisitions. Editorial Staff Mar 15
Money Briefing: Is Boston Scientific Corp. (BSX) Pull Back Overdone as Financial Results Impress? Strategic angle: Boston Scientific Corp. shows strong financial results, raising questions about the recent stock pullback. Editorial Staff Mar 15
Money Briefing: Gilead Sciences, Inc. (GILD): Growth Prospects Backed by Analyst Upgrades Strategic angle: Analysts are optimistic about Gilead Sciences' future growth, leading to recent upgrades. Editorial Staff Mar 15
Money Briefing: Is Pfizer Inc. (PFE) One of Goldman Sachs Top Healthcare Stocks? Strategic angle: An analysis of Pfizer's position among Goldman Sachs' recommended healthcare investments. Editorial Staff Mar 15
Money Briefing: Senate Democrats oppose SAVE America Act as Republicans prepare for floor vote Strategic angle: Senate Democrats remain opposed to SAVE America Act as Republicans prepare for floor vote this week. Here's what to know. Editorial Staff Mar 15
Money Briefing: Democrats blast FCC Chair Carr's broadcast license threats as anti-First Amendment, 'totalitarian' Strategic angle: Carr on Saturday blasted broadcasters shortly after President Donald Trump called reports that Iran struck five U.S. tanker planes 'fake news.' Editorial Staff Mar 15
Money Briefing: A Healthcare Hedge Fund Just Added $24.5 Million in Immunovant Stock. Should you? Strategic angle: Explore the implications of a significant investment by a hedge fund in Immunovant and what it could mean for potential investors. Editorial Staff Mar 15
Money Briefing: WSJ Opinion: Hits and Misses of the Week - MarketWatch Strategic angle: A recap of the week's financial highlights and lowlights. Editorial Staff Mar 15
Money Briefing: Is AbbVie Inc. (ABBV) A Good Stock to Buy Now? Strategic angle: An analysis of AbbVie Inc.'s stock potential for investors. Editorial Staff Mar 15
Money Briefing: Is Linde plc (LIN) A Good Stock To Buy? Strategic angle: An analysis of Linde plc's stock potential. Editorial Staff Mar 15
Money Briefing: Is Rocket Companies, Inc. (RKT) A Good Stock To Buy? Strategic angle: An analysis of Rocket Companies, Inc. (RKT) as a potential investment. Editorial Staff Mar 15
Money Stock Market Week: Nvidia's AI Woodstock, Fed Meeting, Quad Witching A look at the key events impacting the stock market this week, including Nvidia's AI developments and the Federal Reserve meeting. Editorial Staff Mar 15
Money Briefing: Is Regeneron Pharmaceuticals, Inc. (REGN) A Good Stock To Buy? Strategic angle: An analysis of Regeneron Pharmaceuticals, Inc. and its investment potential. Editorial Staff Mar 15
Money Briefing: Another popular barbecue chain files for Chapter 11 bankruptcy Strategic angle: The financial struggles of a well-known barbecue chain lead to its filing for bankruptcy protection. Editorial Staff Mar 15
Money Briefing: CNQGF Stock Price | China Qinfa Group Ltd. Stock Quote (U.S.: OTC) Strategic angle: Latest updates on CNQGF stock price and market performance. Editorial Staff Mar 15
Money Briefing: India hails talks with Iran to open Strait of Hormuz Strategic angle: Foreign minister S Jaishankar tells FT diplomacy ‘is yielding results’ as Trump touts sending warships. Editorial Staff Mar 15
Money Briefing: My Top Growth Stock to Buy for 2026 (and It's Not Even Close) Strategic angle: Discover the leading growth stock poised for significant gains in 2026. Editorial Staff Mar 15
Money Briefing: S&P 500 Rule Change Could Boost Elon Musk-Led SpaceX's Entry Into Index: Report Strategic angle: A potential rule change in the S&P 500 may facilitate SpaceX's inclusion in the index, according to recent reports. Editorial Staff Mar 15